Association of Serum Uric Acid with Non-Valvular Atrial Fibrillation: A Retrospective Study in China
DOI: https://doi.org/10.2147/ijgm.s458089
IF: 2.145
2024-04-23
International Journal of General Medicine
Abstract:Hua-Jing Yuan, 1 Hua-Chen Jiao, 2 Xiu-Juan Liu, 2 Hao Hao, 2 Yang Liu, 2 Yi-Tao Xue, 2 Yan Li 2 1 Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, 250014, People's Republic of China; 2 Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, 250014, People's Republic of China Correspondence: Yi-Tao Xue; Yan Li, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shanshi East Road, Lixia District, Jinan City, Shandong Province, People's Republic of China, Tel +86-531-82602943 ; +86-531-68611662, Email ; Purpose: The association between serum uric acid (SUA) and atrial fibrillation (AF) has been widely focused on and studied in recent years. However, the exact association between SUA and AF is unclear, and the effect of gender on the association between SUA levels and AF has been controversial. This study aimed to investigate the association between SUA levels and non-valvular AF (NVAF) and the potential effect of gender on it. Patients and Methods: A total of 866 NVAF patients (463 males, age 69.44 ± 8.07 years) and 646 sex-matched control patients in sinus rhythm, with no history of arrhythmia were included in this study. t -test, ANOVA, and chi-square test were used for baseline data analysis. The receiver operating characteristic curve, logistic regression and Pearson correlation analysis were used for correlation analysis. Results: Compared to controls, NVAF patients exhibited higher SUA (P< 0.001). After adjusting for confounders of NVAF, SUA remained significantly associated with NVAF, regardless of gender (OR= 1.31, 95% CI 1.18– 1.43, P< 0.001). SUA demonstrated higher predictability and sensitivity in predicting the occurrence of female NVAF compared to male (area under the curve was 0.68 (95% CI 0.64– 0.72, P< 0.001), sensitivity 87.3%), with the optimal cut-off point identified as 5.72 mg/dL. Furthermore, SUA levels correlated with APOA1, Scr and NT-proBNP in NVAF patients. SUA levels varied significantly among NVAF subtypes. Conclusion: High SUA levels were independently associated with NVAF, regardless of gender. SUA exhibited higher predictability and sensitivity in predicting the occurrence of NVAF in females compared to males. High SUA levels may affect other NVAF-related factors and participate in the pathophysiological process of NVAF. Keywords: serum uric acid, non-valvular atrial fibrillation, gender difference, retrospective study, predictive indicators Atrial fibrillation (AF) is a common cardiac arrhythmia. At present, there are more than 30 million AF patients worldwide, with its incidence and related mortality increased significantly. 1,2 It is predicted that the number of adults with AF in Europe will reach 17.9 million by 2060. 3 Atrial thrombus and subsequent embolic events, including ischemic stroke and other thromboembolisms, are serious complications of AF. Given that AF is widely recognized as a significant risk factor for ischemic stroke, 4,5 its impact on the quality of life and health of patients and socioeconomic burden is significant. Despite the effective prediction of AF using ECG 6 and its treatment with antiarrhythmic drugs and radiofrequency catheter ablation, high recurrence and mortality rates persist. Studies have shown that following a single radiofrequency catheter ablation, only 60.5% of patients maintain sinus rhythm after 37 months of follow-up, and after 42 months of follow-up after multiple radiofrequency catheter ablation, 74.9% of patients maintain sinus rhythm. 7 Therefore, the prevention and treatment of AF cannot be ignored. The pathological mechanism of AF is not yet clear, but inflammation and oxidative stress have been confirmed to play an important role in the occurrence and development of AF. 8,9 Serum uric acid (SUA) is produced by purine catabolism, which induces inflammation in vascular endothelial cells and smooth muscle cells, as well as intracellular oxidative stress, leading to endothelial dysfunction and thus affecting thrombosis and inflammatory responses. 10 The current study found that high SUA levels are strongly associated with cardiovascular disease (CVD) and its adverse events, 11,12 and there is an association with traditional cardiovascular risk factors. 13 SUA levels are significantly associated with inflammatory and oxidative stress pathways. 14,15 It appears that SUA shares the same pathological progression as AF, and multiple studies support the significant association between SUA levels and AF. SUA discrete trajectories were significantly a -Abstract Truncated-
medicine, general & internal